Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sauerbrei

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Onkologie|October 1, 1987
[24-hour CA 15/3 serum concentrations in patients with primary and metastasizing breast cancer]W Jäger, W Sauerbrei, M Diedrich, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMFC Schmoor, W Sauerbrei, G Bastert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1992
Relationship between epidermal growth factor receptor (EGF-R) and various prognostic factors in human endometrial carcinomaG. Birmelin, V. Zimmer, W. Sauerbrei, et al.
Der Radiologe|April 1, 1990
[Differential breast diagnosis using CW-Doppler ultrasound]H Madjar, S Münch, W Sauerbrei, et al.
Fertility and Sterility|August 1, 1988
CA-125 serum concentrations during the menstrual cycleW Jäger, C Meier, L Wildt, et al.
British Journal of Cancer|April 17, 1999
Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)W Sauerbrei, P Royston, H Bojar, et al.
Obstetrics and Gynecology|March 1, 1997
Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonographyH J Prömpeler, H Madjar, W Sauerbrei, et al.
Ultrasound in Medicine & Biology|January 1, 1994
Color Doppler flow criteria of breast lesionsH Madjar, H J Prömpeler, W Sauerbrei, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1990
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]E Merkle, C Seidl, U Fuchs, et al.
Gynecologic Oncology|July 1, 1997
Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA)H G Meerpohl, W Sauerbrei, H Kühnle, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Onkologie|October 1, 1987
[24-hour CA 15/3 serum concentrations in patients with primary and metastasizing breast cancer]W Jäger, W Sauerbrei, M Diedrich, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMFC Schmoor, W Sauerbrei, G Bastert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1992
Relationship between epidermal growth factor receptor (EGF-R) and various prognostic factors in human endometrial carcinomaG. Birmelin, V. Zimmer, W. Sauerbrei, et al.
Der Radiologe|April 1, 1990
[Differential breast diagnosis using CW-Doppler ultrasound]H Madjar, S Münch, W Sauerbrei, et al.
Fertility and Sterility|August 1, 1988
CA-125 serum concentrations during the menstrual cycleW Jäger, C Meier, L Wildt, et al.
British Journal of Cancer|April 17, 1999
Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)W Sauerbrei, P Royston, H Bojar, et al.
Obstetrics and Gynecology|March 1, 1997
Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonographyH J Prömpeler, H Madjar, W Sauerbrei, et al.
Ultrasound in Medicine & Biology|January 1, 1994
Color Doppler flow criteria of breast lesionsH Madjar, H J Prömpeler, W Sauerbrei, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1990
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]E Merkle, C Seidl, U Fuchs, et al.
Gynecologic Oncology|July 1, 1997
Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA)H G Meerpohl, W Sauerbrei, H Kühnle, et al.
Pageof 9